TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells

Mechanical loading and inflammation interact to cause degenerative disc disease and low back pain (LBP). However, the underlying mechanosensing and mechanotransductive pathways are poorly understood. This results in untargeted pharmacological treatments that do not take the mechanical aspect of LBP...

Full description

Bibliographic Details
Main Authors: Elena Cambria, Matthias J. E. Arlt, Sandra Wandel, Olga Krupkova, Wolfgang Hitzl, Fabian S. Passini, Oliver N. Hausmann, Jess G. Snedeker, Stephen J. Ferguson, Karin Wuertz-Kozak
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/7/1736
_version_ 1827712660419903488
author Elena Cambria
Matthias J. E. Arlt
Sandra Wandel
Olga Krupkova
Wolfgang Hitzl
Fabian S. Passini
Oliver N. Hausmann
Jess G. Snedeker
Stephen J. Ferguson
Karin Wuertz-Kozak
author_facet Elena Cambria
Matthias J. E. Arlt
Sandra Wandel
Olga Krupkova
Wolfgang Hitzl
Fabian S. Passini
Oliver N. Hausmann
Jess G. Snedeker
Stephen J. Ferguson
Karin Wuertz-Kozak
author_sort Elena Cambria
collection DOAJ
description Mechanical loading and inflammation interact to cause degenerative disc disease and low back pain (LBP). However, the underlying mechanosensing and mechanotransductive pathways are poorly understood. This results in untargeted pharmacological treatments that do not take the mechanical aspect of LBP into account. We investigated the role of the mechanosensitive ion channel TRPV4 in stretch-induced inflammation in human annulus fibrosus (AF) cells. The cells were cyclically stretched to 20% hyperphysiological strain. TRPV4 was either inhibited with the selective TRPV4 antagonist GSK2193874 or knocked out (KO) via CRISPR-Cas9 gene editing. The gene expression, inflammatory mediator release and MAPK pathway activation were analyzed. Hyperphysiological cyclic stretching significantly increased the IL6, IL8, and COX2 mRNA, PGE2 release, and activated p38 MAPK. The TRPV4 pharmacological inhibition significantly attenuated these effects. TRPV4 KO further prevented the stretch-induced upregulation of IL8 mRNA and reduced IL6 and IL8 release, thus supporting the inhibition data. We provide novel evidence that TRPV4 transduces hyperphysiological mechanical signals into inflammatory responses in human AF cells, possibly via p38. Additionally, we show for the first time the successful gene editing of human AF cells via CRISPR-Cas9. The pharmacological inhibition or CRISPR-based targeting of TRPV4 may constitute a potential therapeutic strategy to tackle discogenic LBP in patients with AF injury.
first_indexed 2024-03-10T18:19:46Z
format Article
id doaj.art-55ba19fd9cee4acc986df1334826d34c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T18:19:46Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-55ba19fd9cee4acc986df1334826d34c2023-11-20T07:23:25ZengMDPI AGCells2073-44092020-07-0197173610.3390/cells9071736TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus CellsElena Cambria0Matthias J. E. Arlt1Sandra Wandel2Olga Krupkova3Wolfgang Hitzl4Fabian S. Passini5Oliver N. Hausmann6Jess G. Snedeker7Stephen J. Ferguson8Karin Wuertz-Kozak9Institute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandResearch Office (Biostatistics), Paracelsus Medical University, 5020 Salzburg, AustriaInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandNeuro- and Spine Center, Hirslanden Klinik St. Anna, 6006 Lucerne, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandInstitute for Biomechanics, ETH Zurich, 8093 Zurich, SwitzerlandMechanical loading and inflammation interact to cause degenerative disc disease and low back pain (LBP). However, the underlying mechanosensing and mechanotransductive pathways are poorly understood. This results in untargeted pharmacological treatments that do not take the mechanical aspect of LBP into account. We investigated the role of the mechanosensitive ion channel TRPV4 in stretch-induced inflammation in human annulus fibrosus (AF) cells. The cells were cyclically stretched to 20% hyperphysiological strain. TRPV4 was either inhibited with the selective TRPV4 antagonist GSK2193874 or knocked out (KO) via CRISPR-Cas9 gene editing. The gene expression, inflammatory mediator release and MAPK pathway activation were analyzed. Hyperphysiological cyclic stretching significantly increased the IL6, IL8, and COX2 mRNA, PGE2 release, and activated p38 MAPK. The TRPV4 pharmacological inhibition significantly attenuated these effects. TRPV4 KO further prevented the stretch-induced upregulation of IL8 mRNA and reduced IL6 and IL8 release, thus supporting the inhibition data. We provide novel evidence that TRPV4 transduces hyperphysiological mechanical signals into inflammatory responses in human AF cells, possibly via p38. Additionally, we show for the first time the successful gene editing of human AF cells via CRISPR-Cas9. The pharmacological inhibition or CRISPR-based targeting of TRPV4 may constitute a potential therapeutic strategy to tackle discogenic LBP in patients with AF injury.https://www.mdpi.com/2073-4409/9/7/1736mechanotransductioncyclic stretchingtransient receptor potential channelgene editinginterleukinslow back pain
spellingShingle Elena Cambria
Matthias J. E. Arlt
Sandra Wandel
Olga Krupkova
Wolfgang Hitzl
Fabian S. Passini
Oliver N. Hausmann
Jess G. Snedeker
Stephen J. Ferguson
Karin Wuertz-Kozak
TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
Cells
mechanotransduction
cyclic stretching
transient receptor potential channel
gene editing
interleukins
low back pain
title TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
title_full TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
title_fullStr TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
title_full_unstemmed TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
title_short TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells
title_sort trpv4 inhibition and crispr cas9 knockout reduce inflammation induced by hyperphysiological stretching in human annulus fibrosus cells
topic mechanotransduction
cyclic stretching
transient receptor potential channel
gene editing
interleukins
low back pain
url https://www.mdpi.com/2073-4409/9/7/1736
work_keys_str_mv AT elenacambria trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT matthiasjearlt trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT sandrawandel trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT olgakrupkova trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT wolfganghitzl trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT fabianspassini trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT olivernhausmann trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT jessgsnedeker trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT stephenjferguson trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells
AT karinwuertzkozak trpv4inhibitionandcrisprcas9knockoutreduceinflammationinducedbyhyperphysiologicalstretchinginhumanannulusfibrosuscells